TableĀ 2

Characteristics and predictors of survival in 451 bigger babies admitted to CMJAH PNICU between 1 January 2013 and 30 June 2015

VariableChildren with the condition (%)Percentage of babies with the condition that died (95% CI)Percentage of babies without the condition that died (95% CI)p Value
Place of birth
Another unit220 (48.7)34.1 (27.8 to 40.4)0.577
Born outside health facility14 (3.1)28.6 (4.9 to 52.3)
CMJAH186 (41.2)30.1 (23.5 to 36.7)
Antenatal care302 (67)27.2 (22.2 to 32.2)26.8 (18.0 to 35.6)0.827
Maternal HIV127 (28.2)32.3 (24.2-40.4)24.9 (20.0-29.9)0.231
Caesarean section169 (37.4)23.6 (17.0 to 30.2)32.9 (25.9 to 40.0)0.31
Male274 (60.8)27.7 (22.4 to 33.0)25.3 (18.8 to 31.8)0.491
Resuscitated at birth98 (21.7)28.6 (19.7 to 37.6)26.1 (21.5 to 30.7)0.619
Early-onset sepsis20 (4.4)20 (2.5 to 37.5)27.1 (22.8 to 31.4)0.664
Meconium aspiration75 (16.6)25.3 (15.5 to 35.1)26.9 (22.4 to 31.4)0.784
Hyaline membrane disease*89 (19.7)16.9 (9.1 to 24.7)29.0 (24.3 to 33.7)0.02
PPHN*45 (10.0)46.7 (32.1 to 61.3)24.4 (20.2 to 28.6)0.002
Surfactant therapy108 (23.9)21.3 (13.4 to 29.0)28.7 (13.4 to 29.0)0.518
Hypotension requiring inotropes*55 (12.2)54.5 (41.3 to 67.7)22.7 (18.6 to 26.8)<0.001
CHD*37 (8.2)54.1 (38.0 to 70.2)25.3 (21.1 to 29.5)<0.001
NEC43 (9.5)37.2 (22.8 to 51.7)25.3 (21.1 to 29.5)0.35
Surgery (excluding NEC)129 (28.6)23.3 (16.0 to 30.6)28.0 (23.1 to 32.9)0.395
Hyperglycaemia*46 (10.2)41.3 (27.1 to 55.5)24.9 (20.7 to 29.1)0.017
Metabolic acidosis*48 (10.6)56.3 (42.3 to 70.3)23.1 (19.0 to 27.2)<0.001
Late-onset sepsis119 (26.4)29.4 (21.2 to 37.6)25.6 (20.9 to 30.3)0.420
Major birth defect*146 (32.4)36.3 (28.5 to 44.1)22.0 (17.4 to 26.7)0.002
  • *Statistically significant predictors of survival on univariate analysis.

  • CHD, congenital heart disease; CMJAH, Charlotte Maxeke Johannesburg Academic Hospital; NEC, necrotising enterocolitis; PNICU, paediatric/neonatal intensive care unit; PPHN, persistent pulmonary hypertension of the neonate.